anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

187,801-187,860 of 319,975

filter-aware
05
BioNTech | Results Presentation Deck | 32 slidesBioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
06
BioNTech | Results Presentation Deck | 32 slidesBioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
07
Uses a three-column horizontal progression layout representing time horizons.BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
08
BioNTech | Results Presentation Deck | 32 slidesBioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
09
The slide uses a three-row layout to categorize updates into label expansion, distribution, and R&D progress.BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
10
The chart shows the rapid succession of Omicron sub-lineages in the USA between Dec 2021 and June 2022.BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
11
The slide uses a process-oriented layout to show how three workstreams converge into a single launch event.BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
12
BioNTech | Results Presentation Deck | 32 slidesBioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
13
Data shows monovalent BA.1 and bivalent vaccines as 4th doses; includes LOD line and statistical superiority/non-inferiority notes.BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
14
The slide uses a 3D protein structure visualization and a heatmap to show mutation differences between Omicron lineages.BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
15
The chart uses a logarithmic scale for the y-axis (pVN50 titer).BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
16
The slide outlines three distinct R&D pillars for COVID-19 vaccines.BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
17
The slide uses a Gantt-style visualization to represent clinical trial phases for various drug candidates.BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
18
The slide uses a process flow diagram to illustrate patient stratification into different treatment cohorts.BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
19
Includes a citation to a Nature Medicine paper and a pipeline table.BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
20
Includes bar chart of neoantigen counts, line chart of immune response over time, and Kaplan-Meier survival curve.BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
21
The slide highlights the mechanism of action for bispecific antibodies and a monospecific HexaBody, emphasizing their role in T cell and NK cell activation.BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
22
BioNTech | Results Presentation Deck | 32 slidesBioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
23
BioNTech | Results Presentation Deck | 32 slidesBioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
24
BioNTech | Results Presentation Deck | 32 slidesBioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
25
Includes earnings per share data and footnotes regarding rounding and collaboration profit sharing.BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
26
BioNTech | Results Presentation Deck | 32 slidesBioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
27
BioNTech | Results Presentation Deck | 32 slidesBioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
28
Includes footnotes detailing market definitions and data sources.BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
29
BioNTech | Results Presentation Deck | 32 slidesBioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
30
The slide uses a grouped table structure to categorize milestones by therapeutic area.BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
31
BioNTech | Results Presentation Deck | 32 slidesBioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
32
BioNTech | Results Presentation Deck | 32 slidesBioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
01
Slide 1
Blue Apron | Results Presentation Deck | 25 slidesBlue Apron | Results Presentation Deck | 25 slides · Blue Apron
Conference presentation Investor relations 1 hit
02
Includes company logo in top right corner.Blue Apron | Results Presentation Deck | 25 slides · Blue Apron
Conference presentation Investor relations 1 hit
03
Blue Apron | Results Presentation Deck | 25 slidesBlue Apron | Results Presentation Deck | 25 slides · Blue Apron
Conference presentation Investor relations 1 hit
04
Blue Apron | Results Presentation Deck | 25 slidesBlue Apron | Results Presentation Deck | 25 slides · Blue Apron
Conference presentation Investor relations 1 hit
05
Includes detailed footnotes defining the metrics.Blue Apron | Results Presentation Deck | 25 slides · Blue Apron
Conference presentation Investor relations Beat · Current State1 hit
06
Blue Apron | Results Presentation Deck | 25 slidesBlue Apron | Results Presentation Deck | 25 slides · Blue Apron
Conference presentation Investor relations Beat · Areas for ImprovementLoop · Zoom In1 hit
07
This appears to be a slide from a pitch deck or investor presentation illustrating the product offering and pricing model.Blue Apron | Results Presentation Deck | 25 slides · Blue Apron
Conference presentation Investor relations Beat · Areas for ImprovementLoop · Zoom In1 hit
08
The chart highlights the 'Total Purchase Required' vs 'Sum of Ingredients Used' to illustrate the inefficiency of buying individual ingredients for a single recipe.Blue Apron | Results Presentation Deck | 25 slides · Blue Apron
Conference presentation Investor relations Beat · Areas for ImprovementLoop · Zoom In1 hit
09
The chart uses a dashed horizontal line to visually anchor the Blue Apron price point against the higher-priced restaurant alternatives.Blue Apron | Results Presentation Deck | 25 slides · Blue Apron
Conference presentation Investor relations Beat · Areas for ImprovementLoop · Zoom In1 hit
10
Blue Apron | Results Presentation Deck | 25 slidesBlue Apron | Results Presentation Deck | 25 slides · Blue Apron
Conference presentation Investor relations Beat · Strategic InitiativesLoop · Build Up1 hit
11
The slide uses a logo-grid to establish credibility through association with well-known corporate partners.Blue Apron | Results Presentation Deck | 25 slides · Blue Apron
Conference presentation Investor relations Beat · Strategic InitiativesLoop · Build Up1 hit
12
Blue Apron | Results Presentation Deck | 25 slidesBlue Apron | Results Presentation Deck | 25 slides · Blue Apron
Conference presentation Investor relations Beat · Strategic InitiativesLoop · Build Up1 hit
13
Blue Apron | Results Presentation Deck | 25 slidesBlue Apron | Results Presentation Deck | 25 slides · Blue Apron
Conference presentation Investor relations Beat · Strategic InitiativesLoop · Build Up1 hit
14
Uses a three-column layout to categorize ESG progress.Blue Apron | Results Presentation Deck | 25 slides · Blue Apron
Conference presentation Investor relations Beat · Strategic Initiatives1 hit
15
Blue Apron | Results Presentation Deck | 25 slidesBlue Apron | Results Presentation Deck | 25 slides · Blue Apron
Conference presentation Investor relations Beat · Strategic Initiatives1 hit
16
The chart displays a dual-axis style visualization (though only one axis is explicitly labeled for revenue) showing revenue bars and customer count line points.Blue Apron | Results Presentation Deck | 25 slides · Blue Apron
Conference presentation Investor relations Beat · Strategic Initiatives1 hit
17
Includes YoY growth percentages for each metric and detailed footnotes defining the metrics and accounting for specific impacts.Blue Apron | Results Presentation Deck | 25 slides · Blue Apron
Conference presentation Investor relations Beat · Strategic Initiatives1 hit
18
Blue Apron | Results Presentation Deck | 25 slidesBlue Apron | Results Presentation Deck | 25 slides · Blue Apron
Conference presentation Investor relations Beat · Strategic Initiatives1 hit
19
The slide presents two key performance indicators over a five-quarter period.Blue Apron | Results Presentation Deck | 25 slides · Blue Apron
Conference presentation Investor relations Beat · Strategic Initiatives1 hit
20
The slide uses a split-chart layout to compare two key financial metrics over time.Blue Apron | Results Presentation Deck | 25 slides · Blue Apron
Conference presentation Investor relations Beat · Strategic Initiatives1 hit
21
Blue Apron | Results Presentation Deck | 25 slidesBlue Apron | Results Presentation Deck | 25 slides · Blue Apron
Conference presentation Investor relations 1 hit
22
Blue Apron | Results Presentation Deck | 25 slidesBlue Apron | Results Presentation Deck | 25 slides · Blue Apron
Conference presentation Investor relations 1 hit
23
Blue Apron | Results Presentation Deck | 25 slidesBlue Apron | Results Presentation Deck | 25 slides · Blue Apron
Conference presentation Investor relations 1 hit
24
Standard financial reconciliation table.Blue Apron | Results Presentation Deck | 25 slides · Blue Apron
Conference presentation Investor relations 1 hit
25
Blue Apron | Results Presentation Deck | 25 slidesBlue Apron | Results Presentation Deck | 25 slides · Blue Apron
Conference presentation Investor relations 1 hit
01
Slide 1
BMO Capital Markets | Investment Banking Pitch Book | 22 slidesBMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Situation & Context1 hit
02
BMO Capital Markets | Investment Banking Pitch Book | 22 slidesBMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Situation & Context1 hit
03
The slide compares a benchmark against the Rio Tinto proposal using various financial metrics.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Situation & ContextLoop · Logic Chain1 hit
04
The chart highlights the initial premium at the time of the offer and the current premium relative to the peer group index.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Situation & ContextLoop · Logic Chain1 hit
05
Includes three distinct charts: production volume, cost curve, and country risk premium.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Situation & ContextLoop · Logic Chain1 hit
06
The chart displays a transition from debt-heavy years to dividend-paying years, with a corresponding copper price table at the bottom.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Problem & ComplicationLoop · Logic Chain1 hit
07
Includes Copper Transactions Greater than US$1.0 bn since 2010. Medians exclude Rio Tinto - Turquoise Hill and BHP - OZ Minerals.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Problem & ComplicationLoop · Logic Chain1 hit